SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001625101-19-000029
Filing Date
2019-08-08
Accepted
2019-08-08 16:35:35
Documents
60
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q plse-20190630x10q.htm 10-Q 1480114
2 EX-31.1 plse-20190630xex31_1.htm EX-31.1 20431
3 EX-31.2 plse-20190630xex31_2.htm EX-31.2 20818
4 EX-32.1 plse-20190630xex32_1.htm EX-32.1 19240
  Complete submission text file 0001625101-19-000029.txt   5087109

Data Files

Seq Description Document Type Size
5 EX-101.INS plse-20190630.xml EX-101.INS 968582
6 EX-101.SCH plse-20190630.xsd EX-101.SCH 35603
7 EX-101.CAL plse-20190630_cal.xml EX-101.CAL 50291
8 EX-101.DEF plse-20190630_def.xml EX-101.DEF 133817
9 EX-101.LAB plse-20190630_lab.xml EX-101.LAB 313648
10 EX-101.PRE plse-20190630_pre.xml EX-101.PRE 266845
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Filer) CIK: 0001625101 (see all company filings)

IRS No.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37744 | Film No.: 191010085
SIC: 3841 Surgical & Medical Instruments & Apparatus